Stroke research has identified that mammalian target of rapamycin (mTOR) activity is often elevated during a stroke event, and that inhibiting this activity can promote beneficial autophagy, thereby enhancing neuronal survival by removing damaged organelles [104]. The gene discussed is MTOR; the disease is stroke disorder.